MedPath

Ribose

Generic Name
Ribose
Drug Type
Small Molecule
Chemical Formula
C5H10O5
CAS Number
50-69-1
Unique Ingredient Identifier
681HV46001

Overview

Ribose is under investigation in clinical trial NCT01727479 (Ribose and Sport Performance).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Mito-Charge Powder
394750
RN Labs Pty Ltd
Medicine
A
8/26/2022
Ultra Muscleze Energy
308361
Medicine
A
8/20/2018
NMN 999
323607
Cellife Health Products Pty Ltd
Medicine
A
9/16/2019
NMN996
323606
Cellife Health Products Pty Ltd
Medicine
A
9/16/2019
Mag Extra
404537
Medicine
A
2/8/2023
Electrolytes
409774
RN Labs Pty Ltd
Medicine
A
5/30/2023

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.